Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAPIEN Ultra RESILIA Durability EU Registry - The RESOUND-EU Registry

NCT06953206 is registered in ClinicalTrials.gov with Institut für Pharmakologie und Präventive Medizin as lead sponsor.

NCT NCT06953206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06953206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAPIEN Ultra RESILIA Durability EU Registry - The RESOUND-EU Registry
Lead sponsor
Institut für Pharmakologie und Präventive Medizin
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2025
Completion date
September 30, 2037
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic insufficiency, aortic-stenosis, degenerative valve disease, transcatheter aortic valve replacement (tavr)